Uterine Artery Ligation to Decrease Blood Loss With Central Placenta Previa
Not Applicable
Completed
- Conditions
- Placenta Previa Without Hemorrhage
- Interventions
- Procedure: Uterine artery ligation
- Registration Number
- NCT02002026
- Lead Sponsor
- Minia Maternity University Hospital
- Brief Summary
This trial will address the effect of uterine artery ligation during Cesarean section in cases with placenta previa to decrease blood loss.
- Detailed Description
This Study will address the effect of uterine artery ligation prior to fetal delivery during Cesarean section in cases with central placenta previa to guard against postpartum hemorrhage and to minimize blood loss.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 52
Inclusion Criteria
- Placenta previa is diagnosed when the lowest placental edge is located within 5 cm of the internal os at ultrasound
- Symptomatic Placenta previa with at least one episode of bleeding
- Estimated gestational age within 28 to 40 weeks
- Maternal age > 18 years
- Informed consent
- Social affiliation
Exclusion Criteria
- Premature rupture of membranes
- Severe bleeding.
- Abnormal fetal heart rates.
- Pre-eclampsia, chorioamnionitis, severe chronic renal disease.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ligation group Uterine artery ligation Uterine artery ligation will be done for patients in this group Control group Uterine artery ligation Conventional CS
- Primary Outcome Measures
Name Time Method Changes in hemoglobin level hemoglobin level will be done baseline and will be repeated 24 hours after delivery Changes in hemoglobin level before and after CS will reflect the amount of blood loss during operation
- Secondary Outcome Measures
Name Time Method Degree of uterine contractility. During CS and within 3 hours after CS
Trial Locations
- Locations (1)
Minia Maternity University Hospital
🇪🇬Minia, Egypt